191 related articles for article (PubMed ID: 28424841)
1. Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer.
Ogino I; Watanabe S; Sakamaki K; Ogino Y; Kunisaki C; Kimura K
Strahlenther Onkol; 2017 Jul; 193(7):552-560. PubMed ID: 28424841
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients.
Fukada J; Shigematsu N; Takeuchi H; Ohashi T; Saikawa Y; Takaishi H; Hanada T; Shiraishi Y; Kitagawa Y; Fukuda K
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):487-93. PubMed ID: 23968770
[TBL] [Abstract][Full Text] [Related]
3. Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer.
Xue J; Han C; Jackson A; Hu C; Yao H; Wang W; Hayman J; Chen W; Jin J; Kalemkerian GP; Matuzsak M; Jolly S; Kong FS
Radiother Oncol; 2019 Apr; 133():213-219. PubMed ID: 30416046
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram.
Takeuchi Y; Murakami Y; Kameoka T; Ochi M; Imano N; Takahashi I; Nishibuchi I; Kimura T; Kawahara D; Saito A; Nagata Y
J Radiat Res; 2020 Mar; 61(2):298-306. PubMed ID: 32052040
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.
Wei X; Liu HH; Tucker SL; Wang S; Mohan R; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):707-14. PubMed ID: 18191334
[TBL] [Abstract][Full Text] [Related]
6. Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer.
Pao TH; Chang WL; Chiang NJ; Lin CY; Lai WW; Tseng YL; Lin FC
Radiat Oncol; 2020 Feb; 15(1):48. PubMed ID: 32103779
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for pericardial effusion in patients with stage I esophageal cancer treated with chemoradiotherapy.
Tamari K; Isohashi F; Akino Y; Suzuki O; Seo Y; Yoshioka Y; Hayashi Y; Nishida T; Takehara T; Mori M; Doki Y; Ogawa K
Anticancer Res; 2014 Dec; 34(12):7389-93. PubMed ID: 25503178
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer.
Ogino I; Watanabe S; Iwahashi N; Kosuge M; Sakamaki K; Kunisaki C; Kimura K
Strahlenther Onkol; 2016 Jun; 192(6):359-67. PubMed ID: 26884226
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer-comparison of four-field technique and traditional two opposed fields technique.
Takata N; Kataoka M; Hamamoto Y; Tsuruoka S; Kanzaki H; Uwatsu K; Nagasaki K; Mochizuki T
J Radiat Res; 2018 May; 59(3):291-297. PubMed ID: 29659940
[TBL] [Abstract][Full Text] [Related]
10. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for pericardial effusion identified by heart dose-volume histogram analysis in oesophageal cancer patients treated with chemoradiotherapy.
Hayashi K; Fujiwara Y; Nomura M; Kamata M; Kojima H; Kohzai M; Sumita K; Tanigawa N
Br J Radiol; 2015 Feb; 88(1046):20140168. PubMed ID: 25429644
[TBL] [Abstract][Full Text] [Related]
12. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
[TBL] [Abstract][Full Text] [Related]
13. Pericardial and pleural effusions after definitive radiotherapy for esophageal cancer.
Fukada J; Shigematsu N; Ohashi T; Shiraishi Y; Takeuchi H; Kawaguchi O; Kitagawa Y
J Radiat Res; 2012; 53(3):447-53. PubMed ID: 22739014
[TBL] [Abstract][Full Text] [Related]
14. Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.
He L; Chapple A; Liao Z; Komaki R; Thall PF; Lin SH
Radiother Oncol; 2016 Oct; 121(1):70-74. PubMed ID: 27562616
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients.
Shirai K; Tamaki Y; Kitamoto Y; Murata K; Satoh Y; Higuchi K; Nonaka T; Ishikawa H; Katoh H; Takahashi T; Nakano T
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1002-7. PubMed ID: 20542385
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Lee J; Lin JB; Sun FJ; Lu KW; Lee CH; Chen YJ; Huang WC; Liu HC; Wu MH
Br J Radiol; 2016 Oct; 89(1066):20160350. PubMed ID: 27556422
[TBL] [Abstract][Full Text] [Related]
17. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
[TBL] [Abstract][Full Text] [Related]
18. The heart's exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study.
Hayashi Y; Iijima H; Isohashi F; Tsujii Y; Fujinaga T; Nagai K; Yoshii S; Sakatani A; Hiyama S; Shinzaki S; Makino T; Yamasaki M; Ogawa K; Doki Y; Takehara T
BMC Cancer; 2019 Mar; 19(1):195. PubMed ID: 30832605
[TBL] [Abstract][Full Text] [Related]
19. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
